These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2622858)

  • 1. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
    Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
    Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of food on the absorption of controlled-release theophylline in mini-swine.
    Shiu GK; Sager AO; Velagapudi RB; Prasad VK; Skelly JP
    Pharm Res; 1988 Jan; 5(1):48-52. PubMed ID: 3244609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline bioavailability in the dog.
    Tse FL; Szeto DW
    J Pharm Sci; 1982 Nov; 71(11):1301-3. PubMed ID: 7175732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of food intake on the pharmacokinetics, metabolism and urinary excretion of two sustained release theophylline preparations in nonanesthetized dogs].
    Suzuki S; Sakumoto S; Miyazaki H; Taneike T
    Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):361-8. PubMed ID: 2379886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theophylline: pharmacokinetics, metabolism and urinary excretion in dogs].
    Kuze T; Miyazaki H; Taneike T
    Nihon Yakurigaku Zasshi; 1988 May; 91(5):325-34. PubMed ID: 3410380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
    Lohmann A; Dingler E; Sommer W
    Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
    Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
    Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
    Sagara K; Kawata M; Mizuta H; Shibata M
    Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
    Ikegami K; Tagawa K; Osawa T
    J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of two sustained-release theophylline formulations in the dog.
    Mengozzi G; Intorre L; Bertini S; Giorgi M; Soldani G
    Pharmacol Res; 1998 Dec; 38(6):481-5. PubMed ID: 9990658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions.
    Steinijans VW; Schulz HU; Böhm A; Beier W
    Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD; McKiernan BC; Neff-Davis CA; Munsiff IJ
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of two Soviet sustained-release theophylline formulations in comparison with TheoDur.
    Kiivet RA; Teder P; Pruunsild T; Svensson JO
    Pharmacol Toxicol; 1992 Nov; 71(5):388-90. PubMed ID: 1448452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of food on bioavailability from two controlled-release granules of theophylline.
    Tada H; Ishikawa M; Sato E; Suzuki T; Unno K; Miura K; Ohmiya Y; Nakai K
    J Clin Pharm Ther; 1989 Apr; 14(2):145-51. PubMed ID: 2722977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of caffeine on circulating theophylline levels in beagle dogs.
    Tse FL; Valia KH; Szeto DW; Raimondo TJ; Koplowitz B
    J Pharm Sci; 1981 Apr; 70(4):395-9. PubMed ID: 7229951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.